Suppr超能文献

通过单次注射人CXC趋化因子GROβ的特定截短形式SB-251353快速动员具有增强植入特性的小鼠造血干细胞,并评估恒河猴造血祖细胞的动员情况。

Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta.

作者信息

King A G, Horowitz D, Dillon S B, Levin R, Farese A M, MacVittie T J, Pelus L M

机构信息

Department of Molecular Virology and Host Defense, SmithKline Beecham Pharmaceuticals, Collegeville, PA 19426-0989, USA.

出版信息

Blood. 2001 Mar 15;97(6):1534-42. doi: 10.1182/blood.v97.6.1534.

Abstract

SB-251353 is an N-terminal truncated form of the human CXC chemokine GRObeta. Recombinant SB-251353 was profiled in murine and rhesus monkey peripheral blood stem cell mobilization and transplantation models. SB-251353 rapidly and transiently mobilized hematopoietic stem cells and neutrophils into the peripheral blood after a single subcutaneous injection. Transplantation of equivalent numbers of hematopoietic stem cells mobilized by SB-251353 into lethally irradiated mice resulted in faster neutrophil and platelet recovery than stem cells mobilized by granulocyte colony-stimulating factor (G-CSF). A single injection of SB-251353 in combination with 4 days of G-CSF administration resulted in augmented stem and progenitor cell mobilization 5-fold greater than G-CSF alone. Augmented stem cell mobilization could also be demonstrated in mice when a single injection of SB-251353 was administered with only one-day treatment with G-CSF. In addition, SB-251353, when used as a single agent or in combination with G-CSF, mobilized long-term repopulating stem cells capable of hematopoietic reconstitution of lethally irradiated mice. In rhesus monkeys, a single injection of SB-251353 induced rapid increases in peripheral blood hematopoietic progenitor cells at a 50-fold lower dose than in mice, which indicates a shift in potency. These studies provide evidence that the use of SB-251353 alone or in combination with G-CSF mobilizes hematopoietic stem cells with long-term repopulating ability. In addition, this treatment may (1) reduce the number of apheresis sessions and/or amount of G-CSF required to collect adequate numbers of hematopoietic stem cells for successful peripheral blood cell transplantation and (2) improve hematopoietic recovery after transplantation.

摘要

SB - 251353是人类CXC趋化因子GROβ的N端截短形式。在小鼠和恒河猴外周血干细胞动员及移植模型中对重组SB - 251353进行了分析。单次皮下注射后,SB - 251353能迅速且短暂地将造血干细胞和中性粒细胞动员到外周血中。将等量由SB - 251353动员的造血干细胞移植到接受致死性照射的小鼠体内,与由粒细胞集落刺激因子(G - CSF)动员的干细胞相比,中性粒细胞和血小板恢复得更快。单次注射SB - 251353并联合4天的G - CSF给药,导致干细胞和祖细胞动员量比单独使用G - CSF增加了5倍。当单次注射SB - 251353仅与G - CSF进行一天的联合治疗时,在小鼠中也能证明干细胞动员量增加。此外,SB - 251353单独使用或与G - CSF联合使用时,能动员具有长期重建造血能力的长期造血干细胞,这些干细胞能够对接受致死性照射的小鼠进行造血重建。在恒河猴中,单次注射SB - 251353能诱导外周血造血祖细胞迅速增加,其剂量比在小鼠中低50倍,这表明其效力发生了变化。这些研究提供了证据,证明单独使用SB - 251353或与G - CSF联合使用能动员具有长期重建造血能力的造血干细胞。此外,这种治疗方法可能(1)减少为成功进行外周血细胞移植收集足够数量造血干细胞所需的单采次数和/或G - CSF用量,以及(2)改善移植后的造血恢复。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验